top of page
In the Media
Catalent and MigVax Sign Agreement to Develop an Orally Disintegrating Freeze-Dried Tablet Vaccine Against COVID-19
June 7th, 2022
MigVax Appoints Ran Amir As Its New CEO
May 31st, 2022
CEPI announces first funding awards in quest to develop ‘variant-proof’ COVID-19 vaccines - Partnerships with MigVax Ltd and the University of Saskatchewan’s VIDO
MigVax’s Subunit Oral COVID-19 Vaccine Preclinical Trial Demonstrates Effectivity as a Booster
Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
Israeli Scientists Work To Test Adapted New Avian Virus Vaccine Agains Human Coronavirus
Israeli Lab Working on the Coronavirus Vaccine
Optimism at the Israeli Research Institute: "Hope the vaccine will provide a solution to Corona"
Gli scienziati israeliani sono vicini allo sviluppo di un vaccino per il Coronavirus
Will a Galilee research institute find a vaccine for Corona?
The vaccine race: Will success come from a lab in Kiryat Shmona?
bottom of page